WuXi AppTec Receives Inaugural “Company of the Year” Award from BayHelix

We are honored to announce that WuXi has received the inaugural “Company of the Year” Award from BayHelix. The award is part of the BayHelix China Healthcare Awards series, celebrating outstanding...

WuXi’s STA Biotech CMC Outsourcing Boston Symposium Recap

WuXi’s STA Pharmaceutical recently hosted a knowledge sharing and networking symposium, “Biotech CMC Outsourcing Strategies – Boston.” More than 100 industry CMC professionals and collaborators participated in this event, which focused...

WuXi’s STA Leaders Provide Industry Trends and Insights During CPhI Worldwide 2016

More than 36,000 pharma professionals from over 150 countries attended the CPhI Worldwide 2016 convention in Barcelona Spain earlier this month to stay updated on the latest industry trends, meet with global...

WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies

We are thrilled to announce the grand opening of our Center for Clinical and Commercial Manufacturing of Advanced Therapies in the Philadelphia Navy Yard. The 150,000 square foot biomanufacturing facility is designed...

WuXi Biologics Completes Construction of Asia’s Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors

We are pleased to announce the opening of our new commercial-scale cGMP biologics perfusion manufacturing facility in the city of Wuxi, China. The $150 million commercial biologics manufacturing facility accommodates two 1000L...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Game Changer: Scientist Mark Waller Ready to “Go” to Next level...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx)   Renowned chemist and computational scientist Mark Waller is ready to go to the next...